Novel Bragg peak FLASH radiotherapy: treatment of base-of-skull tumors within existing clinical guidelines.

Pennock M, Selvaraj B, Cheng C, Kyler A, Lin H, Hasan S, Chhabra A, Choi JI, Bakst R, Kabarriti R, Lee NY, Simone CB, Kang M.Front Oncol. 2026 Sep 4;16:1909184. doi: 10.3389/fonc.2026.1909184. eCollection 2026.PMID: 42761104 Free PMC article.

Upright Immobilization for Proton Therapy: A Critical Review and Single-Institution Experience.

Aissi S, O’Reilly S, Harari C, Morris B, Slagowski J, Bassetti M, Morris Z, Durkee B, Glide-Hurst C, Kang M.Int J Radiat Oncol Biol Phys. 2026 Sep 7:S0360-3016(26)04256-2. doi: 10.1016/j.ijrobp.2026.08.066. Online ahead of print.PMID: 42705358 Review.

Bispecific GD2xB7-H3 Antibody Improves Tumor Targeting and Reduces Toxicity while Maintaining Efficacy for Neuroblastoma.

Erbe AK, Feils AS, Reinthaler SN, Hampton A, Rosenkrans ZT, Guevara Y, Felder M, Wiwczar J, Gerhardt DJ, Bercher M, Wenke B, Haertle C, Heck M, Heimstreet K, Frankel E, Nielsen M, Spiegelman D, Tsarovsky N, Zaborek J, Rakhmilevich AL, Hank JA, Aluicio-Sarduy E, Engle JW, Davis JH, Glaser B, Subbotin V, Green R, Hernandez R, Hammer B, Sondel PM.bioRxiv [Preprint]. 2026 Sep 22:2026.09.21.753180. doi: 10.64898/2026.09.21.753180.PMID: 42818194 Free PMC article. Preprint.

Low-dose radiopharmaceutical therapy enhances the efficacy of B7-H3 CAR T cells in murine metastatic neuroblastoma.

Shea AG, Ollendorff A, Wilke A, Shi L, Erbe AK, Ansari IH, Idrissou MB, Kwon O, Rojas HC, Barisa M, Anderson J, Eickhoff JC, Ong I, Richards RM, Sondel PM, Capitini CM, Hernandez R, Bednarz BP, Weichert JP, Morris ZS, Sodji QH.bioRxiv [Preprint]. 2026 Sep 22:2026.09.16.751528. doi: 10.64898/2026.09.16.751528.PMID: 42817928 Free PMC article. Preprint.

Reproducibility of perfusion blood volume and ventilation imaging for lung function assessment.

Sharma M, Tyerech C, Alexander D, Lai C, Tie X, Hovland P, Friedes C, Hollawell C, Yegya-Raman N, O’Reilly S, Zou JW, Cengel K, Levin W, Bradley JD, Feigenberg SJ, Kevin Teo BK.Phys Med Biol. 2026 Sep 21;71(18). doi: 10.1088/1361-6560/aea51b.PMID: 42716107

Circulating Tumor DNA (ctDNA) Clearance After Immune Checkpoint Inhibition (ICI) with Radiotherapy (RT) as a Prognostic Biomarker for Advanced Melanoma.

Steimle AK, Forati AM, Zhou AY, McCracken T, Hosny MM, Rahimi G, Patel JD, Burkey C, Caraway J, Huppe T, Wood A, Harris MS, Birbrair A, Ayuso JM, Sahasrabudhe DM, Hollnagel F, Doolittle GC, Burr AR, Mathew NS, In GK, Victor A, Ma VT.Cancers (Basel). 2026 Sep 18;18(18):3032. doi: 10.3390/cancers18183032.PMID: 42794998 Free PMC article.

Enabling gantry-less radiotherapy through upright patient positioning: Current consensus and future direction.

Trnkova P, Underwood T, Bokrantz R, Engwall E, Glide-Hurst C, Garibaldi C, Glimelius L, Inaniva T, Jäkel O, Jolly S, Lomax T, Martire MC, Patera V, Placidi L, Pryanichnikov A, Rinaldi I, Sands G, Troost EGC, Vai A, Zhang Y, Volz L.Radiother Oncol. 2026 Sep 18;225:111785. doi: 10.1016/j.radonc.2026.111785. Online ahead of print.PMID: 42759615 Free article. Review.

Beyond Cancer: Functional Radiation Medicine at an Inflection Point.

Bajaj GK, Martin J, Robinson CG, Bredel M, Merrell K, Thomas E, Plastaras JP, Schuster J, Wilson E.Adv Radiat Oncol. 2026 Sep 11;11(9):102162. doi: 10.1016/j.adro.2026.102162. eCollection 2026 Sep.PMID: 42746311 Free PMC article. No abstract available.

In Situ Vaccination, Low-Dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models.

Debnath T, Jin WJ, Patel RB, Carlson PM, Rahman MM, Berg TJ, Kerr CP, Schwartz RW, Wang Y, Hyun M, Ong IM, Weichert JP, Hernandez R, Sondel PM, Morris ZS.Cancer Immunol Res. 2026 Sep 2;14(9):1416-1432. doi: 10.1158/2326-6066.CIR-25-1475.PMID: 42418729 Free PMC article.

Molecular Classification Refines Adjuvant Radiation Therapy Use in Stage III Endometrial Cancer Exhibiting No Specific Molecular Profile.

Brower JV, Clements A, Chino J, Havrilesky L, Melamed A, Secord AA, Klopp AH.Pract Radiat Oncol. 2026 Sep-Oct;16(5):507-512. doi: 10.1016/j.prro.2026.01.012. Epub 2026 Mar 31.PMID: 41914949 No abstract available.

Robust optimization of catheter positions and dwell times for HDR prostate brachytherapy.

Schulz JB, Bednarz BP, Floberg JM, Slagowski JM.Med Phys. 2026 Sep;53(9):e70640. doi: 10.1002/mp.70640.PMID: 42613864 Free PMC article.

Deep learning auto-contouring of target and organs-at-risk on post-catheter implant CT images for prostate HDR brachytherapy.

Wallat EM, Schulz JB, Floberg JM, Cooley G, Bednarz BP, Slagowski JM.J Appl Clin Med Phys. 2026 Sep;27(9):e70748. doi: 10.1002/acm2.70748.PMID: 42613795 Free PMC article.